EPSTI1 Is Involved in IL-28A-Mediated Inhibition of HCV Infection

EPSTI1 Is Involved in IL-28A-Mediated Inhibition of HCV Infection

It has been reported that IFN-λs inhibit HCV replication in vitro. But the mechanisms of how IL-28A conducts antiviral activity and the functions of IL-28A-induced ISGs (IFN-stimulated genes) are not fully understood. In this study, we found that IL-28A has the antiviral effect on HCV life cycle inc...

Full description

Bibliographic Details
Main Authors:	Xianghe Meng, Darong Yang, Rong Yu, Haizhen Zhu
Format:	Article
Language:	English
Published:	Hindawi Limited 2015-01-01
Series:	Mediators of Inflammation
Online Access:	http://dx.doi.org/10.1155/2015/716315

Similar Items

Tryptophan Breakdown in Patients with HCV Infection is Influenced by IL28B Polymorphism
by: Heinz Zoller, et al.
Published: (2015-06-01)

Impact of Immunogenetic IL28B Polymorphism on Natural Outcome of HCV Infection
by: Valli De Re, et al.
Published: (2014-01-01)

Breast cancer genes PSMC3IP and EPSTI1 play a role in apoptosis regulation.
by: Eva Capdevila-Busquets, et al.
Published: (2015-01-01)

MiR-942 mediates hepatitis C virus-induced apoptosis via regulation of ISG12a.
by: Darong Yang, et al.
Published: (2014-01-01)

Comparison of IL-28B favorable genotype frequency between healthy and patients infected with HCV
by: Javad Moayedi, et al.
Published: (2018-06-01)

CircEPSTI1 Promotes the Progression of Non-Small Cell Lung Cancer Through miR-145/HMGB3 Axis
by: Xie Y, et al.
Published: (2020-08-01)

Recent research on association between gene polymorphisms of IL-28B and other cytokines and HCV infection
by: MAO Yijia, et al.
Published: (2015-08-01)

Type III interferons, IL-28 and IL-29, are increased in chronic HCV infection and induce myeloid dendritic cell-mediated FoxP3+ regulatory T cells.
by: Angela Dolganiuc, et al.
Published: (2012-01-01)

IL-28B polymorphisms correlated with treatment response in HCV-4 mono-infected patients: a meta-analysis.
by: Tonggang Liu, et al.
Published: (2014-01-01)

Relationship between gene polymorphism of IL-28B and clinical, laboratory, virologic parameters in patients with chronic HCV-infection
by: K. V. Zhdanov, et al.
Published: (2014-12-01)

Studying the Frequency of Favorable Allele of rs12979860 Polymorphism of IL-28B in Healthy and HCV Infected Iranian Individuals
by: Abdolvahab Alborzi, et al.
Published: (2015-08-01)

SNP rs8099917 in Gene IL28B Might Be Associated with Risk of Chronic Infection by HCV but Not with Response to Treatment
by: Simone Regina Souza da Silva Conde, et al.
Published: (2014-01-01)

IL28B gene polymorphism rs12979860, but not rs8099917, contributes to the occurrence of chronic HCV infection in Uruguayan patients
by: Natalia Echeverría, et al.
Published: (2018-03-01)

Pharmacogenetics of efficacy and safety of HCV treatment in HCV-HIV coinfected patients: significant associations with IL28B and SOCS3 gene variants.
by: Francesc Vidal, et al.
Published: (2012-01-01)

ASSOCIATION BEETWEEN IL-28β POLYMORPHISMS AND EFFECTIVENESS OF CONCOMITANT THERAPY OF HIV INFECTION IN PATIENTS WITH HCV/HIV CO-INFECTION DURING THE ANTIVIRAL THERAPY
by: E. S. Kovaleva
Published: (2014-07-01)

The Association of Il28b Genotype with the Histological Features of Chronic Hepatitis C Is HCV Genotype Dependent
by: Roberta D'Ambrosio, et al.
Published: (2014-04-01)

Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication
by: Nelson David R, et al.
Published: (2005-09-01)

Polymorphism of Interleukin 28 and HCV: Implementation of a method
by: Alessandra Flaminio, et al.
Published: (2012-12-01)

2-octynoic acid inhibits hepatitis C virus infection through activation of AMP-activated protein kinase.
by: Darong Yang, et al.
Published: (2013-01-01)

Impact of IL28B genetic variation on HCV-induced liver fibrosis, inflammation, and steatosis: a meta-analysis.
by: Masaya Sato, et al.
Published: (2014-01-01)

Role of IL-28B polymorphisms in virologic response to combined pegylated interferon and ribavirin therapy in genotype 4 chronic HCV infected patients with and without cirrhosis
by: Amira Youssef Shaala, et al.
Published: (2015-09-01)

None of the six SNPs of IL28B could predict treatment responses in genotype 2 chronic HCV infected patients by propensity score matching analysis.
by: Wen-Juei Jeng, et al.
Published: (2012-01-01)

Progression of liver fibrosis in HIV/HCV genotype 1 co-infected patients is related to the T allele of the rsI2979860 polymorphism of the <it>IL28B </it>gene
by: Lutz P, et al.
Published: (2011-08-01)

Inhibition of hepatitis C virus infection by DNA aptamer against NS2 protein.
by: Yimin Gao, et al.
Published: (2014-01-01)

HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection.
by: Sonya A MacParland, et al.
Published: (2016-01-01)

Increased levels of circulating IL-10 in persons recovered from hepatitis C virus (HCV) infection compared with persons with active HCV infection
by: Dorcas Ohui Owusu, et al.
Published: (2020-10-01)

Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection.
by: Ying Zhang, et al.
Published: (2011-01-01)

MDSCs mediate angiogenesis and predispose canine mammary tumor cells for metastasis via IL-28/IL-28RA (IFN-λ) signaling.
by: Joanna Mucha, et al.
Published: (2014-01-01)

Prevalence of HIV, Hepatitis B and C Infections and an Assessment of HCV-Genotypes and Two IL28B SNPs among People Who Inject Drugs in Three Regions of Nepal.
by: Hans-Tilmann Kinkel, et al.
Published: (2015-01-01)

Correlation between IL28B/TLR4 genetic variants and HCC development with/without DAAs treatment in chronic HCV patients
by: Ghada M. Salum, et al.
Published: (2020-09-01)

GP73 is upregulated by hepatitis C virus (HCV) infection and enhances HCV secretion.
by: Longbo Hu, et al.
Published: (2014-01-01)

Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal.
by: Sudhamshu Kc, et al.
Published: (2020-12-01)

IL28B alleles exert an additive dose effect when applied to HCV-HIV coinfected persons undergoing peginterferon and ribavirin therapy.
by: Barham K Abu Dayyeh, et al.
Published: (2011-01-01)

High frequencies of a favorable IL-28B rs8099917 polymorphism and the clinical implications in patients with HCV in one multiracial area of Taiwan
by: Chun-Han Cheng, et al.
Published: (2017-10-01)

Identification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoprotein.
by: Reem R Al Olaby, et al.
Published: (2014-01-01)

Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection
by: Pécheur Eve-Isabelle, et al.
Published: (2006-07-01)

Heme and HO-1 inhibition of HCV, HBV, and HIV
by: Warren N Schmidt, et al.
Published: (2012-10-01)

Inhibition of HCV by the serpin antithrombin III
by: Asmal Mohammed, et al.
Published: (2012-10-01)

Molecular Mechanism Involved in HIV-Tat Mediated inhibition of LPS-Induced IL-23 and IL-27 Production in Human Macrophages
by: Gajanayaka, Niranjala
Published: (2015)

LncRNAs in HCV Infection and HCV-Related Liver Disease
by: Juan P. Unfried, et al.
Published: (2020-03-01)